Literature DB >> 4155170

Pharmacokinetic criteria for the evaluation of retard formulations.

J Meier, E Nüesch, R Schmidt.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4155170     DOI: 10.1007/bf00560355

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  2 in total

1.  [Remarks on the pharmacokinetics of drugs administered into the muscles].

Authors:  G Medgyesi; P Medgyesi
Journal:  Pharmazie       Date:  1967-05       Impact factor: 1.267

Review 2.  Pharmacokinetics of drug action.

Authors:  G Levy; M Gibaldi
Journal:  Annu Rev Pharmacol       Date:  1972       Impact factor: 13.820

  2 in total
  20 in total

Review 1.  Pharmacokinetic characterization of controlled-release formulations.

Authors:  V W Steinijans
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

2.  Enhancement of the oral absorption of cyclosporin in man.

Authors:  J Drewe; R Meier; J Vonderscher; D Kiss; U Posanski; T Kissel; K Gyr
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

Review 3.  Controversies in bioequivalence studies.

Authors:  V W Steinijans; D Hauschke; J H Jonkman
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

4.  Pharmacokinetics and pharmacodynamics of a new transdermal delivery system for bopindolol.

Authors:  J Drewe; R Meier; U Timonen; M Thumshirn; J Munzer; T Kissel; K Gyr
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

5.  Pharmacokinetics and pharmacodynamics of conventional and controlled-release formulations of metipranolol in man.

Authors:  R Lapka; T Sechser; V Rejholec; M Peterková; M Votavová
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Plasma prednisolone levels from enteric and non-enteric coated tablets estimated by an original technique.

Authors:  P J Morrison; I D Bradbrook; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

Review 7.  Metrics for the evaluation of bioequivalence of modified-release formulations.

Authors:  Laszlo Endrenyi; Laszlo Tothfalusi
Journal:  AAPS J       Date:  2012-08-22       Impact factor: 4.009

8.  Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects.

Authors:  T Kissel; J Drewe; S Bantle; A Rummelt; C Beglinger
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

9.  Pharmacokinetics of slow-release diltiazem and its effect on atrioventricular conduction in healthy volunteers.

Authors:  A Gordin; P Pohto; S Sundberg; S Nykänen; H Haataja; P Männistö
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  In vitro and in vivo evaluation of single-unit commercial conventional tablet and sustained-release capsules compared with multiple-unit polystyrene microparticle dosage forms of Ibuprofen.

Authors:  Shunmugaperumal Tamilvanan; Biswanath Sa
Journal:  AAPS PharmSciTech       Date:  2006-09-01       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.